Login / Signup

Real-world experience on the efficacy and safety of apremilast in bio-naïve patients with moderate plaque psoriasis.

Andrea ContiRossana Tiberio
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Keyphrases
  • coronary artery disease
  • high intensity